Logo designed by Diane Saunders (Vanderbilt University)


Upcoming Seminar

Wednesday, July 7th, 2021

Panel Discussion: “Hot topics: in vitro modeling of molecular interactions between SARS-CoV2 and diabetes”

In the early months of the Covid19 pandemic, individuals with metabolic syndrome or diabetes appeared to have elevated risk for Covid19-related mortality, but the molecular mechanisms underlying this elevated risk were unknown. Additionally, some reports suggested that infection with SARS-CoV2 enhanced rates of glucose intolerance, prediabetes, and new onset diabetes. Whether diabetes alters the vulnerability of various cell types to SARS-CoV2 infection and if SARS-CoV2 infection alters the metabolic function of the pancreas, liver, adipose, lung, and other important metabolic tissues has been areas of intense investigation over the past year. This panel will discuss current evidence from cellular models about the molecular and cellular interaction between SARS-CoV2 and diabetes, highlighting areas where broad consensus has been reached and areas where more evidence is needed.

Carmella Evans-Molina, MD, PhD

Director, IU Center for Diabetes and Metabolic Diseases

Indiana University

Peter Jackson, PhD

Professor of Microbiology & Immunology and of Pathology

Stanford University

Shuibing Chen, PhD

Associate Professor, Director of  Diabetes Program in Surgery

Weill Cornell University

About the DRC Virtual Seminar Series

The Virtual Diabetes Research Center Seminar Series began as an effort to connect investigators and trainees during this time of great change and isolation related to the COVID crisis. This seminar series is organized by the NIDDK-funded Diabetes Research Centers at the Albert Einstein College of Medicine, Columbia University, Joslin Diabetes Center, Indiana University, Stanford University, the University of Alabama at Birmingham, UCSD/UCLA, UCSF, the University of Chicago, the University of Colorado, the University of Michigan, the University of Washington, Vanderbilt University, Washington University, Yale University, and in North Carolina (logos and connections below). Each seminar in the series features an outstanding scientist or panel of scientists discussing the latest in diabetes, obesity, or metabolic research.

The seminars are held on the second Wednesday of the month at (2:00 PM ET | 1:00 PM CT | 12:00 PM MT | 11:00 AM PT) unless this date coincides with a federal holiday. All webinars are free to attend. Trainees are encouraged to sign-up to meet with speakers after each seminar.

Spring 2021 Schedule

Date & Time

01/13 at
1:00 PM CT

02/10 at
1:00 PM CT

03/10 at
1:00 PM CT

04/14 at
1:00 PM CT

05/12 at
1:00 PM CT

06/09 at
1:00 PM CT


Felicia Hill-Briggs, PhD, ABPP (Johns Hopkins)

E. Dale Abel, MD, PhD
(University of Iowa)

Debbie C. Thurmond, PhD
(City of Hope)

COVID-19 Panel

William Parker, MD, MS

Monica Peek, MD, MPH, MS, FACP

Kamlesh Khunti, MD, PhD, FRCP, FRCGP, FMedSci

Jose C. Florez, MD, PhD

Darleen Sandoval, PhD
(Univ. Colorado)


“Social Determinants of Health and Diabetes: Focusing a Newer Lens”

“Diabetes and Heart Failure – Mitochondrial Mechanisms”

“Insulin secretion and peripheral Insulin action: orchestrating better harmony” *Recording will be available at a later date

“COVID-19 Vaccine Distribution Disparities”

“Racial/Ethnic Disparities in the COVID-19 Pandemic”

“COVID-19 and Its Impact in People with Diabetes”

“Clinical Translation of Genetic Predictors for Type 2 Diabetes”

“Lessons from mouse models of bariatric surgery”

07/07 at
1:00 PM CT

COVID and Diabetes Panel

Carmella Evans-Molina, MD, PhD

Peter Jackson, PhD

Shuibing Chen, PhD

“Hot topics: in vitro modeling of molecular interactions between SARS-CoV2 and diabetes”